Hyper IgM Syndrome is characterized by immunodeficiency with elevated serum IgM and low or absent other immunoglobulins due to a defect in class switching recombination. The most common form is X-linked Hyper IgM Syndrome caused by mutations in the CD40 ligand gene, affecting approximately 1 in 1,000,000 males. Clinical manifestations include recurrent respiratory and gastrointestinal infections. Treatment involves hematopoietic stem cell transplantation which is curative but has better outcomes when performed at a younger age before organ damage develops.
Common variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia, poor response to vaccination, and increased susceptibility to infection. It is the most common symptomatic antibody deficiency disorder. The pathogenesis of CVID involves defects in B cell differentiation and antibody production that can be caused by genetic mutations affecting surface molecules, cytosolic proteins, or nuclear factors involved in B cell development and antibody class switching. While most cases of CVID are sporadic, about 5-25% show familial inheritance in an autosomal dominant pattern.
The document discusses mast cell activation syndrome (MCAS), including the development and classification of mast cells, clinical manifestations of MCAS, diagnostic criteria for MCAS under various consensus guidelines from 2010 to 2022, and treatments for MCAS. MCAS is diagnosed based on recurrent symptoms affecting multiple organ systems as well as elevated mast cell mediators that respond to treatments targeting mast cell mediators. Diagnostic criteria have evolved over time to rely more on clinical symptoms and treatment response compared to specific mast cell marker thresholds.
Chronic spontaneous urticaria (CSU) is characterized by the development of hives and angioedema for more than 6 weeks without triggering factors. It affects 1% of the population. CSU is diagnosed through patient history and physical exam. Treatment involves high dose antihistamines as first line, with omalizumab recommended for severe cases. Management aims to control symptoms and improve quality of life through a treatment plan evaluated every 3-6 months.
The document outlines selective immunoglobulin A deficiency, defined as a serum IgA level less than 7 mg/dL in individuals over 4 years old with normal IgG, IgM, and a normal IgG antibody response to vaccination. It discusses the condition's initial description in 1964 and lists key diagnostic criteria established by immunology societies.
Common variable immune deficiency (CVID) is the most common and clinically significant primary antibody deficiency. It is defined by low levels of immunoglobulins IgG, IgA and/or IgM and impaired antibody production. Patients present with recurrent infections, autoimmunity, lymphoproliferation or malignancy. While the cause is unknown in most cases, genetic defects have been identified in a minority of patients. Treatment involves immunoglobulin replacement therapy, treatment of infections and complications, and monitoring for associated conditions. Prognosis has improved with treatment but morbidity and mortality remain higher than the general population.
Hyper IgM Syndrome is characterized by immunodeficiency with elevated serum IgM and low or absent other immunoglobulins due to a defect in class switching recombination. The most common form is X-linked Hyper IgM Syndrome caused by mutations in the CD40 ligand gene, affecting approximately 1 in 1,000,000 males. Clinical manifestations include recurrent respiratory and gastrointestinal infections. Treatment involves hematopoietic stem cell transplantation which is curative but has better outcomes when performed at a younger age before organ damage develops.
Common variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia, poor response to vaccination, and increased susceptibility to infection. It is the most common symptomatic antibody deficiency disorder. The pathogenesis of CVID involves defects in B cell differentiation and antibody production that can be caused by genetic mutations affecting surface molecules, cytosolic proteins, or nuclear factors involved in B cell development and antibody class switching. While most cases of CVID are sporadic, about 5-25% show familial inheritance in an autosomal dominant pattern.
The document discusses mast cell activation syndrome (MCAS), including the development and classification of mast cells, clinical manifestations of MCAS, diagnostic criteria for MCAS under various consensus guidelines from 2010 to 2022, and treatments for MCAS. MCAS is diagnosed based on recurrent symptoms affecting multiple organ systems as well as elevated mast cell mediators that respond to treatments targeting mast cell mediators. Diagnostic criteria have evolved over time to rely more on clinical symptoms and treatment response compared to specific mast cell marker thresholds.
Chronic spontaneous urticaria (CSU) is characterized by the development of hives and angioedema for more than 6 weeks without triggering factors. It affects 1% of the population. CSU is diagnosed through patient history and physical exam. Treatment involves high dose antihistamines as first line, with omalizumab recommended for severe cases. Management aims to control symptoms and improve quality of life through a treatment plan evaluated every 3-6 months.
The document outlines selective immunoglobulin A deficiency, defined as a serum IgA level less than 7 mg/dL in individuals over 4 years old with normal IgG, IgM, and a normal IgG antibody response to vaccination. It discusses the condition's initial description in 1964 and lists key diagnostic criteria established by immunology societies.
Common variable immune deficiency (CVID) is the most common and clinically significant primary antibody deficiency. It is defined by low levels of immunoglobulins IgG, IgA and/or IgM and impaired antibody production. Patients present with recurrent infections, autoimmunity, lymphoproliferation or malignancy. While the cause is unknown in most cases, genetic defects have been identified in a minority of patients. Treatment involves immunoglobulin replacement therapy, treatment of infections and complications, and monitoring for associated conditions. Prognosis has improved with treatment but morbidity and mortality remain higher than the general population.
1) The document outlines an overview of chronic spontaneous urticaria (CSU), including its epidemiology, clinical presentation, natural history, and pathogenesis.
2) CSU affects approximately 0.5-1% of the general population and is more common in adults than children, with a peak age of onset between 20-40 years.
3) The pathogenesis of CSU is not fully understood but is believed to involve inappropriate activation of mast cells and basophils by autoantibodies, leading to the release of inflammatory mediators that cause wheals and angioedema.
Selective IgA deficiency is the most common primary antibody deficiency, where there is an absence of IgA antibodies in the blood and secretions. IgA antibodies help protect mucosal surfaces from infection. While most people with selective IgA deficiency are asymptomatic, some experience recurrent sinopulmonary or gastrointestinal infections. The condition is diagnosed through blood tests showing low or absent IgA levels alongside normal levels of other antibodies. Treatment focuses on preventing infections and managing any associated conditions. The prognosis is generally good, though there is a small risk of developing other immune deficiencies.
This document provides an overview of IgG4-Related disease including its epidemiology, pathogenesis, clinical presentation, diagnostic criteria, and organ involvement. Some key points include:
- It predominantly affects men aged 50-70 years.
- Pathogenesis involves IgG4-positive plasma cells and T-helper type 2 immune responses leading to fibrosis and organ swelling.
- Diagnosis requires specific histological findings and elevated serum IgG4 levels.
- It can affect many organs including lacrimal glands, salivary glands, lungs, pancreas, kidney, and lymph nodes, causing swelling.
Approach to a child with suspected immunodefeciencyNitin Pawar
Immunodeficiency can be primary (genetic) or secondary (acquired) and results in increased susceptibility to infections. Primary immunodeficiencies can affect T cells, B cells, phagocytes, or the complement system. Secondary immunodeficiencies are caused by drugs, infections like HIV. Incidence is estimated at 1 in 10,000 people. Diagnosis involves assessing infection history and family history, immunological testing like immunoglobulin levels and antibody titers, and genetic testing if a specific mutation is known. Early diagnosis and treatment like antibiotics, immunoglobulin replacement or bone marrow transplant can be life-saving.
Autoimmune hemolytic anemia (or autoimmune haemolytic anaemia; AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to insufficient plasma concentration.
By Dr. Usama Ragab Youssif
Definitions & Nomenclatures
Structure of immunoglobulins
Immunoglobulins in our bodies
Physiologic actions of immunoglobulins
The Idea behind use of immunoglobulins
Uses: indications, mechanisms, preparation, posology, administration
Adverse effects
Safe practice
Final bottom-line
Hypereosinophilic Syndrome (HES) is a rare condition characterized by elevated levels of eosinophils in the blood (eosinophilia) and tissue damage caused by eosinophils. The document discusses the historical background, definition, pathogenesis, epidemiology, classification, and clinical manifestations of HES. It defines HES based on eosinophilia greater than 1500 cells/microliter for more than 6 months with evidence of organ damage after ruling out other causes. HES can be classified into myeloproliferative and lymphocytic forms based on the underlying pathogenesis. The myeloproliferative form involves mutations in hematopoietic cells that drive eosinophil production while the lymphocy
This document discusses hypereosinophillic syndrome (HES), which is defined as persistent eosinophilia with organ involvement. It outlines the biology of eosinophils and defines reactive vs idiopathic hypereosinophilia. HES can be classified as myeloproliferative- or lymphocytic-variant based on underlying cause. Common organ systems involved are heart, lungs, skin and nervous system. The document recommends investigations to identify underlying causes and excludes other conditions. It also discusses treatment options for HES, including corticosteroids and targeted therapies depending on the identified genetic abnormality or cytokine driving eosinophil production.
Hyper-IgE Syndrome, also known as Job's syndrome or Buckley's syndrome, is a rare primary immunodeficiency disorder characterized by elevated serum immunoglobulin E (IgE) levels, eczema, recurrent skin and lung infections, and a distinctive facial appearance. There are both autosomal dominant and recessive forms. The autosomal dominant form is caused by mutations in the STAT3 gene and is characterized by clinical features including newborn rash, boils, pneumonia, pneumatoceles, and elevated IgE levels above 2000 IU/mL. Patients often have a characteristic facial appearance, dental abnormalities, fractures from minimal trauma, and brain and vascular abnormalities. The disorder results from defects in the JAK
Intravenous immunoglobulin (IVIG) is prepared from pooled human plasma and contains concentrated IgG antibodies. It is used to treat primary immunodeficiencies in patients who do not produce sufficient antibodies. IVIG is administered monthly at a dose of 300-600 mg/kg to maintain protective IgG trough levels. The dosage may be increased or decreased based on the patient's clinical response and infection history. IVIG treatment requires monitoring for efficacy and adverse reactions. The appropriate IVIG product and administration method depends on the individual patient's diagnosis, medical history, and tolerability.
Hyper-IgE Syndrome is characterized by elevated immunoglobulin E levels and recurrent skin and lung infections. It can be caused by autosomal dominant or recessive mutations. Autosomal dominant Hyper-IgE Syndrome is caused by STAT3 deficiency and is associated with eczema, pneumonia, skeletal abnormalities, and connective tissue problems. Autosomal recessive Hyper-IgE Syndrome is caused by DOCK8 deficiency and has additional neurological symptoms, malignancies, and food allergies compared to the dominant form. Both forms involve immunological defects and require treatment and management of infections.
CD antigens, also known as clusters of differentiation, are cell surface proteins that are used to identify and characterize cell types. Over 371 CD markers have been identified that serve important functions like cell signaling. CD markers are analyzed using techniques like flow cytometry and help diagnose diseases like leukemia by identifying abnormal levels of specific CD antigens. Key CD markers have been identified for important immune cells like T cells, B cells, granulocytes, and stem cells. Immunophenotyping using CD markers is an important application in diagnosing diseases and monitoring treatment responses.
Alpha-Gal Syndrome, also known as red meat allergy, is caused by IgE antibodies against the carbohydrate galactose-alpha-1,3-galactose (α-Gal) found in most mammals except primates. Tick bites transmit α-Gal to humans, causing an immune response. Reactions to red meat occur 2-6 hours after consumption due to the delayed absorption of α-Gal from glycoproteins and glycolipids. Management involves avoiding red meat, organs, and secondary exposures. The syndrome is increasingly recognized globally where ticks that transmit α-Gal are present.
This document provides an overview of hyper IgE syndrome (HIES). It discusses the two main classifications of HIES - autosomal dominant (AD-HIES) and autosomal recessive (AR-HIES). AD-HIES is caused by mutations in the STAT3 gene and is characterized by eczema, respiratory infections, and elevated IgE levels, as well as skeletal and connective tissue abnormalities. AR-HIES can be caused by mutations in DOCK8, TYK2, PGM3, or other genes. It presents similarly to AD-HIES immunologically but without skeletal features. Laboratory findings include elevated IgE, eosinophilia, and lymphopenia. Management involves treatment
Intravenous immunoglobulin (IVIG) preparations are derived from pooled human plasma containing predominantly IgG. IVIG is used for IgG replacement therapy in immunocompromised patients at doses of 0.5 g/kg, and for suppression of autoimmune diseases at higher doses of 1-3 g/kg. IVIG has numerous proposed mechanisms of action including Fc receptor blockade, cytokine neutralization, modulation of B cell and T cell function, and inhibition of complement deposition. IVIG is administered intravenously over 2-4 hours, while subcutaneous immunoglobulin (SCIG) is infused weekly via pump at doses approximating IVIG therapy.
This document provides an overview of immunoglobulin E (IgE) and IgE receptors. It discusses the history and discovery of IgE, the structure and function of IgE, and IgE receptors such as FcεRI and CD23. It also covers the clinical significance of IgE levels in various diseases, including allergic diseases, infections, and non-atopic diseases. IgE plays an important role in type I hypersensitivity reactions and defense against parasites. The production and role of IgE is highly complex and involves interactions between immune cells, cytokines, and environmental exposures.
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
Omalizumab is an anti-IgE monoclonal antibody approved for treating allergic asthma, chronic urticaria, and other allergic diseases. It binds to IgE and forms complexes that are cleared, reducing free IgE levels and decreasing FcεRI expression on mast cells and basophils. For asthma, omalizumab improves symptoms and lung function and reduces exacerbations and steroid use. It may be more effective in patients with elevated type 2 biomarkers. Omalizumab also improves symptoms of chronic urticaria by decreasing mediators released in response to autoantibodies. Other anti-IgE biologics in development have distinct binding properties from omalizumab.
This document summarizes allergen immunotherapy (AIT) for allergic diseases. It discusses the immune mechanisms of AIT, efficacy for conditions like allergic rhinitis and asthma, indications and contraindications. It also covers topics like allergen selection and preparation, dosing protocols, routes of administration, duration of treatment, and safety considerations. The overall goal of AIT is to decrease allergic inflammation and induce tolerance through regulatory T cells and other immune mechanisms.
Immunoglobulins are glycoprotein antibodies produced by plasma cells in response to antigens. They have Y-shaped structures composed of two heavy chains and two light chains connected by disulfide bonds. The variable regions at the tips of the Y determine antigen binding specificity, while the constant regions mediate effector functions like complement activation. The five major classes in humans are IgG, IgM, IgA, IgD, and IgE, which have different structures, properties, and roles in immunity.
Immunoglobulins are glycoproteins called antibodies that are produced by plasma cells in response to antigens. There are five classes of immunoglobulins - IgG, IgA, IgM, IgD, and IgE - which have different structures and roles in the immune system. IgG is the most abundant antibody found in serum and body fluids. IgA is present in secretions like breast milk, saliva, and mucus to provide immunity at body surfaces. IgM is the first antibody produced during infection and activates the complement system. IgE mediates allergic reactions by binding to mast cells.
1) The document outlines an overview of chronic spontaneous urticaria (CSU), including its epidemiology, clinical presentation, natural history, and pathogenesis.
2) CSU affects approximately 0.5-1% of the general population and is more common in adults than children, with a peak age of onset between 20-40 years.
3) The pathogenesis of CSU is not fully understood but is believed to involve inappropriate activation of mast cells and basophils by autoantibodies, leading to the release of inflammatory mediators that cause wheals and angioedema.
Selective IgA deficiency is the most common primary antibody deficiency, where there is an absence of IgA antibodies in the blood and secretions. IgA antibodies help protect mucosal surfaces from infection. While most people with selective IgA deficiency are asymptomatic, some experience recurrent sinopulmonary or gastrointestinal infections. The condition is diagnosed through blood tests showing low or absent IgA levels alongside normal levels of other antibodies. Treatment focuses on preventing infections and managing any associated conditions. The prognosis is generally good, though there is a small risk of developing other immune deficiencies.
This document provides an overview of IgG4-Related disease including its epidemiology, pathogenesis, clinical presentation, diagnostic criteria, and organ involvement. Some key points include:
- It predominantly affects men aged 50-70 years.
- Pathogenesis involves IgG4-positive plasma cells and T-helper type 2 immune responses leading to fibrosis and organ swelling.
- Diagnosis requires specific histological findings and elevated serum IgG4 levels.
- It can affect many organs including lacrimal glands, salivary glands, lungs, pancreas, kidney, and lymph nodes, causing swelling.
Approach to a child with suspected immunodefeciencyNitin Pawar
Immunodeficiency can be primary (genetic) or secondary (acquired) and results in increased susceptibility to infections. Primary immunodeficiencies can affect T cells, B cells, phagocytes, or the complement system. Secondary immunodeficiencies are caused by drugs, infections like HIV. Incidence is estimated at 1 in 10,000 people. Diagnosis involves assessing infection history and family history, immunological testing like immunoglobulin levels and antibody titers, and genetic testing if a specific mutation is known. Early diagnosis and treatment like antibiotics, immunoglobulin replacement or bone marrow transplant can be life-saving.
Autoimmune hemolytic anemia (or autoimmune haemolytic anaemia; AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to insufficient plasma concentration.
By Dr. Usama Ragab Youssif
Definitions & Nomenclatures
Structure of immunoglobulins
Immunoglobulins in our bodies
Physiologic actions of immunoglobulins
The Idea behind use of immunoglobulins
Uses: indications, mechanisms, preparation, posology, administration
Adverse effects
Safe practice
Final bottom-line
Hypereosinophilic Syndrome (HES) is a rare condition characterized by elevated levels of eosinophils in the blood (eosinophilia) and tissue damage caused by eosinophils. The document discusses the historical background, definition, pathogenesis, epidemiology, classification, and clinical manifestations of HES. It defines HES based on eosinophilia greater than 1500 cells/microliter for more than 6 months with evidence of organ damage after ruling out other causes. HES can be classified into myeloproliferative and lymphocytic forms based on the underlying pathogenesis. The myeloproliferative form involves mutations in hematopoietic cells that drive eosinophil production while the lymphocy
This document discusses hypereosinophillic syndrome (HES), which is defined as persistent eosinophilia with organ involvement. It outlines the biology of eosinophils and defines reactive vs idiopathic hypereosinophilia. HES can be classified as myeloproliferative- or lymphocytic-variant based on underlying cause. Common organ systems involved are heart, lungs, skin and nervous system. The document recommends investigations to identify underlying causes and excludes other conditions. It also discusses treatment options for HES, including corticosteroids and targeted therapies depending on the identified genetic abnormality or cytokine driving eosinophil production.
Hyper-IgE Syndrome, also known as Job's syndrome or Buckley's syndrome, is a rare primary immunodeficiency disorder characterized by elevated serum immunoglobulin E (IgE) levels, eczema, recurrent skin and lung infections, and a distinctive facial appearance. There are both autosomal dominant and recessive forms. The autosomal dominant form is caused by mutations in the STAT3 gene and is characterized by clinical features including newborn rash, boils, pneumonia, pneumatoceles, and elevated IgE levels above 2000 IU/mL. Patients often have a characteristic facial appearance, dental abnormalities, fractures from minimal trauma, and brain and vascular abnormalities. The disorder results from defects in the JAK
Intravenous immunoglobulin (IVIG) is prepared from pooled human plasma and contains concentrated IgG antibodies. It is used to treat primary immunodeficiencies in patients who do not produce sufficient antibodies. IVIG is administered monthly at a dose of 300-600 mg/kg to maintain protective IgG trough levels. The dosage may be increased or decreased based on the patient's clinical response and infection history. IVIG treatment requires monitoring for efficacy and adverse reactions. The appropriate IVIG product and administration method depends on the individual patient's diagnosis, medical history, and tolerability.
Hyper-IgE Syndrome is characterized by elevated immunoglobulin E levels and recurrent skin and lung infections. It can be caused by autosomal dominant or recessive mutations. Autosomal dominant Hyper-IgE Syndrome is caused by STAT3 deficiency and is associated with eczema, pneumonia, skeletal abnormalities, and connective tissue problems. Autosomal recessive Hyper-IgE Syndrome is caused by DOCK8 deficiency and has additional neurological symptoms, malignancies, and food allergies compared to the dominant form. Both forms involve immunological defects and require treatment and management of infections.
CD antigens, also known as clusters of differentiation, are cell surface proteins that are used to identify and characterize cell types. Over 371 CD markers have been identified that serve important functions like cell signaling. CD markers are analyzed using techniques like flow cytometry and help diagnose diseases like leukemia by identifying abnormal levels of specific CD antigens. Key CD markers have been identified for important immune cells like T cells, B cells, granulocytes, and stem cells. Immunophenotyping using CD markers is an important application in diagnosing diseases and monitoring treatment responses.
Alpha-Gal Syndrome, also known as red meat allergy, is caused by IgE antibodies against the carbohydrate galactose-alpha-1,3-galactose (α-Gal) found in most mammals except primates. Tick bites transmit α-Gal to humans, causing an immune response. Reactions to red meat occur 2-6 hours after consumption due to the delayed absorption of α-Gal from glycoproteins and glycolipids. Management involves avoiding red meat, organs, and secondary exposures. The syndrome is increasingly recognized globally where ticks that transmit α-Gal are present.
This document provides an overview of hyper IgE syndrome (HIES). It discusses the two main classifications of HIES - autosomal dominant (AD-HIES) and autosomal recessive (AR-HIES). AD-HIES is caused by mutations in the STAT3 gene and is characterized by eczema, respiratory infections, and elevated IgE levels, as well as skeletal and connective tissue abnormalities. AR-HIES can be caused by mutations in DOCK8, TYK2, PGM3, or other genes. It presents similarly to AD-HIES immunologically but without skeletal features. Laboratory findings include elevated IgE, eosinophilia, and lymphopenia. Management involves treatment
Intravenous immunoglobulin (IVIG) preparations are derived from pooled human plasma containing predominantly IgG. IVIG is used for IgG replacement therapy in immunocompromised patients at doses of 0.5 g/kg, and for suppression of autoimmune diseases at higher doses of 1-3 g/kg. IVIG has numerous proposed mechanisms of action including Fc receptor blockade, cytokine neutralization, modulation of B cell and T cell function, and inhibition of complement deposition. IVIG is administered intravenously over 2-4 hours, while subcutaneous immunoglobulin (SCIG) is infused weekly via pump at doses approximating IVIG therapy.
This document provides an overview of immunoglobulin E (IgE) and IgE receptors. It discusses the history and discovery of IgE, the structure and function of IgE, and IgE receptors such as FcεRI and CD23. It also covers the clinical significance of IgE levels in various diseases, including allergic diseases, infections, and non-atopic diseases. IgE plays an important role in type I hypersensitivity reactions and defense against parasites. The production and role of IgE is highly complex and involves interactions between immune cells, cytokines, and environmental exposures.
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
Omalizumab is an anti-IgE monoclonal antibody approved for treating allergic asthma, chronic urticaria, and other allergic diseases. It binds to IgE and forms complexes that are cleared, reducing free IgE levels and decreasing FcεRI expression on mast cells and basophils. For asthma, omalizumab improves symptoms and lung function and reduces exacerbations and steroid use. It may be more effective in patients with elevated type 2 biomarkers. Omalizumab also improves symptoms of chronic urticaria by decreasing mediators released in response to autoantibodies. Other anti-IgE biologics in development have distinct binding properties from omalizumab.
This document summarizes allergen immunotherapy (AIT) for allergic diseases. It discusses the immune mechanisms of AIT, efficacy for conditions like allergic rhinitis and asthma, indications and contraindications. It also covers topics like allergen selection and preparation, dosing protocols, routes of administration, duration of treatment, and safety considerations. The overall goal of AIT is to decrease allergic inflammation and induce tolerance through regulatory T cells and other immune mechanisms.
Immunoglobulins are glycoprotein antibodies produced by plasma cells in response to antigens. They have Y-shaped structures composed of two heavy chains and two light chains connected by disulfide bonds. The variable regions at the tips of the Y determine antigen binding specificity, while the constant regions mediate effector functions like complement activation. The five major classes in humans are IgG, IgM, IgA, IgD, and IgE, which have different structures, properties, and roles in immunity.
Immunoglobulins are glycoproteins called antibodies that are produced by plasma cells in response to antigens. There are five classes of immunoglobulins - IgG, IgA, IgM, IgD, and IgE - which have different structures and roles in the immune system. IgG is the most abundant antibody found in serum and body fluids. IgA is present in secretions like breast milk, saliva, and mucus to provide immunity at body surfaces. IgM is the first antibody produced during infection and activates the complement system. IgE mediates allergic reactions by binding to mast cells.
The document summarizes key aspects of immunoglobulin structure and function. Immunoglobulins are bifunctional proteins with a conserved domain structure that provides structural stability while allowing for infinite antigen binding variability. The immunoglobulin fold consists of beta sheets forming a barrel structure. Hypervariable complementarity determining regions located on antigen binding loops provide diversity in antigen recognition. The Fc region is common to each immunoglobulin isotype and mediates effector functions like complement activation and cell interactions. Each isotype has distinct properties relating to structure, expression levels, half-life and roles in immunity.
This topic covers the brief introduction of Ag and Ab in detail. Types and functions of Ig is explained in detail. Paraproteinemias is explained with simple pictures.
by Dr. N.Sivaranjani, MD
Immunoglobulins, also known as antibodies, are glycoprotein molecules produced by plasma cells that act as a critical part of the immune response by specifically recognizing and binding to particular antigens like bacteria or viruses to aid in their destruction. B-cells produce immunoglobulins and mature through different stages in the fetal liver, bone marrow, lymph nodes, and spleen. The immunoglobulins IgM and IgD act as receptors on B-cells and activate them. Upon re-exposure to a pathogen, memory B-cells quickly produce IgM to mount an immune response. Immunoglobulins have a common structure of four polypeptide chains including both heavy and light chains that allow for antigen recognition.
This document summarizes the structures and types of immunoglobulins. It discusses the five classes of immunoglobulins - IgG, IgM, IgA, IgD, and IgE - and their properties, including what percentage of serum each class comprises and their roles in binding antigens, fixing complement, and inducing immune responses. It also covers immunoglobulin subclasses defined by minor amino acid differences, as well as kappa and lambda light chain types.
Immunoglobulins, also known as antibodies, are Y-shaped glycoproteins produced by B cells that function to recognize and bind to foreign objects like antigens or pathogens. There are five classes of immunoglobulins - IgG, IgM, IgA, IgD, and IgE - which differ in size, sugar content, and biological function. Each immunoglobulin molecule contains two light chains and two heavy chains that form variable and constant regions. The variable regions are responsible for binding to antigens while the constant regions mediate different immune functions.
Vaccines provide immunity to diseases and contain agents that stimulate the immune system. There are several types including whole organism vaccines using killed or attenuated microbes, purified components like toxoids and polysaccharides, recombinant and DNA vaccines. Vaccines work by inducing both antibody and cellular immune responses. While effective, they also carry small risks like adverse reactions that researchers continue working to understand and improve safety.
El documento presenta los resultados de un estudio sobre las tendencias del mercado laboral en Guadalajara realizado entre mayo y junio de 2008. El estudio incluyó encuestas a 396 empresas y 40 entrevistas a profundidad con directivos. Los principales hallazgos fueron que las empresas valoran especialmente las habilidades blandas, el dominio de inglés y herramientas tecnológicas en los egresados. También señalaron que si bien no es un requisito, los estudios de posgrado y experiencia laboral previa son valorados positivamente.
This document provides information on pleural effusions and pleural lesions. It discusses the anatomy and physiology of the pleura, as well as common causes of pleural effusions such as congestive heart failure, pneumonia, and cancer. Various pleural lesions are also described, including pleural thickening, empyema, fibrous tumors, mesothelioma, metastases, and lymphoma. Imaging features of these conditions on chest x-ray and CT are presented, along with appropriate differential diagnoses and diagnostic workup.
The document traces the complex path of allergic and inflammatory reactions. It begins when an allergen enters the body and attracts antibodies like Immunoglobulin E (IgE). This causes the production of enzymes like Phospholipase A2 which break down cell wall phospholipids and produce inflammatory mediators like arachidonic acid. Arachidonic acid then interacts with enzymes like cyclooxygenase and lipoxygenase to produce prostaglandins, thromboxanes, and leukotrienes. These mediators cause symptoms of inflammation like increased mucus and the attraction of cells and mediators that perpetuate the allergic response.
The document discusses different types of vaccines, including:
- Live attenuated vaccines which use weakened live pathogens that cause immunity but not disease. Examples include measles, rubella, and yellow fever vaccines.
- Toxoid vaccines which use inactivated bacterial toxins to provide immunity against diseases caused by toxins like tetanus, diphtheria, and pertussis.
- Subunit vaccines containing purified antigen components rather than whole organisms, like hepatitis B and papilloma virus vaccines.
- Conjugated vaccines join bacterial capsular polysaccharides to proteins to enhance immune response against infections like Hib and pneumococcal.
- Recombinant vaccines produced through genetic engineering techniques
Developmental Biology Special Problem: Benzalkonium Chloride and Drosophila m...Joanna Rose Navarro
This document appears to be a student research paper that investigates the mutagenic effects of benzalkonium chloride on Drosophila melanogaster (fruit flies). The paper includes an introduction discussing background on mutations and why fruit flies are used for this type of study. It also includes the research questions and hypothesis. The methodology section describes how the experiment will be conducted, including preparing the mutagen, collecting fruit fly samples, and observing for visible mutations between generations exposed to the chemical.
This document provides an overview of the adaptive immune system, including definitions of key terms like antigen and antibody. It outlines the differences between innate and adaptive immunity and describes the components, properties, cells, and effectors of the adaptive immune system. Specifically, it defines T cells, B cells, antibodies, humoral and cell-mediated immunity. It also covers antigen presentation, memory responses, tolerance, and the roles of dendritic cells, macrophages and other effectors in the adaptive response.
Allergic rhinitis is a common chronic inflammatory disease of the nasal mucosa affecting 10-20% of the population. It is caused by an IgE-mediated response to airborne allergens like dust mites, pollen, and animal dander. Symptoms include rhinorrhea, nasal congestion, sneezing, and itching. Allergic rhinitis is classified based on symptom duration and severity. Treatment involves avoidance of triggers, oral antihistamines, intranasal corticosteroids, and immunotherapy to relieve symptoms and inflammation. Allergic rhinitis and asthma often co-exist as part of a combined airway inflammatory disease.
T cells secrete cytokines that regulate the adaptive immune response. There are three main subclasses of T cells: Th1 cells that promote cell-mediated immunity, Th2 cells that promote antibody-mediated immunity, and Treg cells that regulate Th1 and Th2 activities. Each T cell subclass secretes different cytokines, such as IL-12 from Th1 cells and IL-4 from Th2 cells. Cytokines also regulate hematopoiesis through colony stimulating factors like EPO, GM-CSF, and G-CSF that drive differentiation of stem cells into specific blood cell lineages.
This document provides information on eosinophils:
- Eosinophils are white blood cells that are characterized by distinctive granules and a bilobed nucleus. They play a role in fighting parasites and allergic responses.
- Eosinophils develop from bone marrow stem cells and are regulated by cytokines like IL-5, IL-3 and GM-CSF. Transcription factors like C/EBP, GATA-1 and PU.1 are required for eosinophil development.
- Eosinophils traffic to tissues where they can persist for over a week. Their granules contain toxic proteins that are released during degranulation which is regulated by cytokines and chemokines.
- Eosin
Radiological imaging of pleural diseases Pankaj Kaira
The document discusses the anatomy, imaging, and common diseases of the pleura. It begins by describing the normal anatomy of the pleural layers and thickness. Common pleural diseases are then reviewed, including pleural effusions, pneumothorax, hemothorax, and empyema. Imaging findings on chest x-ray, ultrasound, CT, and MRI are provided for diagnosing and characterizing various pleural conditions. Key signs that help differentiate pleural, pulmonary, and extra-pleural masses are also outlined.
allergic diseases, atopic,bronchial asthma Hash Shah
This document discusses allergic diseases and their diagnosis. It notes that the incidence of allergic conditions like asthma and allergic rhinitis are rising. Atopy, the genetic predisposition to develop IgE antibodies, involves complex genetic and environmental factors. Allergic disorders are caused by type I hypersensitivity reactions and IgE-mediated immune responses. Diagnosis involves taking a thorough history, and may include nonspecific tests like CBC and IgE levels or more specific tests like skin prick tests and allergen-specific IgE blood tests to identify triggers.
Relevancia clínica de las pruebas tipo eliza para determinación de intoleranc...MEDIAGNOSTIC
This document discusses IgG food allergy testing using ELISA (Enzyme-Linked Immunosorbent Assay). It notes that while IgE-mediated food allergies are well-established, most food allergies involve non-IgE immune responses detectable by IgG testing. The document examines limitations of traditional IgE tests like skin prick tests and discusses advantages of ELISA for detecting both IgE and IgG responses. It emphasizes the importance of IgG in delayed food allergies and outlines technical and quality standards laboratories must meet to ensure ELISA provides reliable, reproducible and valid results.
This document discusses allergy diagnosis and testing. It provides information on:
1. The types of allergies including asthma, rhinitis, food allergy.
2. Allergy tests including skin prick tests, specific IgE tests, basophil histamine release tests.
3. Indications for allergy testing including persistent asthma, occupational exposures, and before immunotherapy.
4. Cases demonstrating how test results along with clinical history are used to diagnose conditions like allergic rhinitis, Churg-Strauss syndrome, and food allergy.
- Ahmed M Ebrahim, an 8-year-old boy, presents with cough, wheezing, dyspnea and has a history of asthma and allergic rhinitis since age 3. He has recurrent swelling behind the ears diagnosed as parotid.
- Examination finds depressed maxillary bones, atrophied nares, oral breathing, and vesicular breathing with rhonchi. Tests show normal CBC.
- The patient likely has Selective IgA Deficiency based on his clinical history of recurrent infections, asthma, and parotid swelling. This is the most common primary immune deficiency where patients have low or absent IgA levels.
This document discusses the immunologic mechanisms of anaphylaxis. It describes IgE-dependent and IgG-mediated pathways that can trigger anaphylaxis through cross-linking of antibodies on mast cells and basophils. It also discusses non-immunologic triggers like direct mast cell activation and complement activation. A variety of mediators are released that can cause signs and symptoms. The classification of reactions and potential effector cells involved are presented.
Alergias mediadas por anticuperpos ig e versus alergias mediadas por iggMEDIAGNOSTIC
IgG-mediated food sensitivity reactions are delayed, taking hours or days to appear after ingesting the offending food. Unlike immediate IgE-mediated food allergies, IgG sensitivities are difficult to detect without specialized testing and can involve multiple foods. Symptoms of IgG food sensitivity can affect any tissue or organ and include conditions like irritable bowel syndrome, asthma, and behavioral issues in children. Testing for IgG antibodies to specific foods can help identify sensitivities and guide elimination diets to improve conditions like rheumatoid arthritis and autism.
The five classes of antibodies are IgG, IgM, IgA, IgD, and IgE. IgG makes up around 80% of antibodies in serum and protects against circulating bacteria and viruses. IgM is involved in the primary response and is the first antibody to appear after infection. IgA is most common in mucous membranes and body secretions where it helps prevent pathogen attachment. IgD's function is unknown, while IgE binds to mast cells and basophils to trigger allergic reactions. Each class has distinct properties, locations, functions, and roles in the immune response.
The document discusses hypersensitivity, which refers to undesirable immune reactions like allergies and autoimmunity. It defines the four types of hypersensitivity reactions classified by Gell and Coombs in 1963. Type I is an immediate hypersensitivity mediated by IgE antibodies binding to allergens and crosslinking mast cells and basophils to release inflammatory mediators. Common allergic disorders include asthma, rhinitis, anaphylaxis, eczema and urticaria. Approximately 20-30% of Indians suffer from at least one allergic disease. Type II involves antibody and complement mediated cell destruction, while Type III and IV are delayed hypersensitivity reactions involving T cells and monocytes.
Role of targeted inhibitors in curing peanut allergyumaima omar
This document discusses using selective IgE inhibition to treat peanut allergies. It outlines testing covalent heterobivalent inhibitors (cHBIs) that target specific binding sites on peanut proteins recognized by IgE antibodies in allergic patients. A study treated 100 peanut allergic patients with cHBIs, finding up to 90% inhibition of allergic responses in samples, suggesting cHBIs may establish a new class of allergy therapeutics by selectively blocking the allergic response without suppressing the immune system.
This document discusses insect allergy, specifically focusing on allergies to bee, wasp, and ant venoms. It covers the epidemiology of insect sting allergies, presenting clinical symptoms, diagnosis, and treatment approaches. For treatment, the document outlines venom immunotherapy (VIT) protocols and effectiveness. VIT using the culprit insect's venom is an effective prevention method, reducing systemic reactions in 95-100% of cases. VIT is recommended to continue for 3-5 years or longer to maintain protection from future stings.
Allergy testing is important for diagnosis of allergic conditions. Skin prick tests and blood tests like specific IgE tests can help identify triggers. Specific IgE tests like ImmunoCAP are more accurate than total IgE and are not affected by medications, skin conditions, or pregnancy. Phadiatop is a useful screening test to detect sensitization to common inhalants and foods. Positive results on screening tests should be followed up with customized allergen panels based on symptoms and environment. Reference lab data shows significant prevalence of sensitization to common allergens like dust mites, pollens, foods in the local population tested. Proper history and examination along with selection of right allergen panels is key to allergy diagnosis
Immunoglobulin G (IgG) is the most abundant type of antibody found in blood and extracellular fluid. It has a Y-shaped structure composed of two heavy chains and two light chains that form antigen-binding sites at each end. IgG plays a key role in the humoral immune response by binding to pathogens to immobilize and neutralize them, and activating the complement system. Deficiencies in IgG subclasses can impair immunity and lead to recurrent infections of the sinuses, lungs, and other organs.
Overlap between allergy and immunedeficiency originallllllFawzia Abo-Ali
Fawzia Abo Ali discusses the relationship between primary immunodeficiencies (PIDs) and allergies. She notes that allergies are sometimes an early warning sign of an underlying PID. PIDs like selective IgA deficiency, hyper IgE syndrome, common variable immunodeficiency, and severe combined immunodeficiency have been associated with higher rates of allergies like asthma and atopic dermatitis. A bias toward TH2 immune responses can also occur in PIDs like CVID. She stresses that PIDs should be considered in patients with severe, treatment-resistant, or infection-prone allergies. Early immunoglobulin testing is important to diagnose PIDs before organ
Indications for anti ig e other than asthma deleanudiana deleanu
Omalizumab, an anti-IgE antibody, is approved for use in moderate-to-severe allergic asthma. The document discusses potential off-label uses of omalizumab in other allergic and respiratory conditions based on its mechanism of action. These include allergic rhinitis, nasal polyposis, chronic sinusitis, allergic bronchopulmonary aspergillosis, Churg-Strauss syndrome, and COPD. Some studies show benefits for conditions like allergic rhinitis and nasal polyposis, but more research is still needed to establish safety and efficacy in other conditions.
Skin prick testing of pediatric allergies copy.pptxdrgsvt
Skin prickly test is the most useful, easiest and affordable investigation to identify the suspected allergen as to the cause of sensitisation … it will detect bound IgE … it is preferred to immunocap assay test…
This document discusses the diagnosis of allergies in children. It covers the significance of allergy tests, various in vivo and in vitro diagnostic tests including skin prick tests, RAST tests, and patch tests. It also discusses the development of allergic diseases and different types of allergic conditions such as allergic rhinitis, asthma, eczema, and food allergies.
This document discusses selective immunoglobulin A (IgA) deficiency. It begins by defining immunoglobulins, antibodies, and the process of class switching that allows antibodies to change class. It then discusses affinity maturation, where antibodies increase in affinity for antigens over time. Selective IgA deficiency is defined as having low or absent levels of the IgA antibody. Causes may include genetics or unknown factors. Risk is higher in Caucasians. Most people are asymptomatic, but some experience recurrent infections. Diagnosis involves blood tests showing low IgA levels. Treatment focuses on infection management and preventative vaccines. IVIG can treat associated deficiencies.
- Cat and dog allergens such as Fel d 1 and Can f 1 are major allergens found in fur, dander, and saliva that can become airborne and cause sensitization in a large percentage of allergic individuals.
- Lipocalins make up many mammalian allergens and show cross-reactivity between species due to structural similarities, explaining co-sensitizations between cats, dogs, horses, and other animals.
- Higher levels of IgE antibodies to specific dog lipocalins are associated with more severe asthma in children with dog allergy.
1) DRESS syndrome is a severe cutaneous drug reaction characterized by fever, lymphadenopathy, hematologic abnormalities, multisystem involvement, and viral reactivation. It has a delayed onset of 2-3 weeks after starting the culprit drug.
2) The skin manifestations are typically a polymorphous maculopapular eruption and facial edema. Systemic involvement can include the liver, kidneys, lungs and other organs.
3) Diagnosis is based on clinical criteria including the RegiSCAR scoring system which evaluates morphology, timing of onset, organ involvement, hematologic abnormalities and viral reactivation.
Wheat is one of the most important global food sources and wheat allergy prevalence varies from 0.4-4% depending on age and region. Several wheat proteins have been identified as major allergens, including omega-5-gliadin, alpha-amylase inhibitors, and glutenins. Studies have found that serum testing for IgE antibodies to specific wheat allergens, such as omega-5-gliadin, glutenins, and alpha-amylase inhibitors, can help diagnose wheat allergy and distinguish between mild and severe cases. Sensitization to different wheat allergens is associated with wheat-dependent exercise-induced anaphylaxis versus occupational baker's asthma. Proper diagnosis and
Major indoor allergens include dust mites, domestic animals like cats and dogs, insects like cockroaches, mice, and fungi. Dust mites thrive in warm, humid environments like mattresses, bedding, and upholstered furniture, where they feed on human skin scales and excrete allergenic fecal particles. Cat allergens like Fel d 1 accumulate in fur and can become airborne, causing worse asthma outcomes in sensitized individuals. Minimizing exposure involves removing carpets, frequent washing of bedding, humidity control, HEPA filtration and ventilation.
This document provides information on Hymenoptera, focusing on the families Apidae and Vespidae. It discusses the epidemiology and prevalence of insect venom allergy. It also covers the taxonomy, venom composition, and clinical manifestations of common stinging insects like honeybees, hornets, wasps and yellow jackets. Key allergens are identified for different species.
- NSAIDs hypersensitivity can present with distinct clinical phenotypes based on organ system involvement and timing of symptoms. It is estimated that less than 20% of reported adverse reactions to NSAIDs are true hypersensitivities.
- AERD/NERD involves eosinophilic rhinosinusitis, asthma, and nasal polyps. Exposure to aspirin or other NSAIDs exacerbates bronchospasms and rhinitis. Management involves lifelong avoidance of culprit and cross-reacting NSAIDs.
- Various phenotypes are described beyond the EAACI classification, including blended reactions involving multiple organs, food-dependent NSAID-induced anaphylaxis, and NSAID-selective immediate reactions. Proper diagnosis relies
The document discusses food immunotherapy for treating food allergies. It provides definitions and outlines immune mechanisms and efficacy evidence from studies on peanut, cow's milk, egg, and wheat oral immunotherapy (OIT). Peanut OIT studies showed 67-78% of children achieved desensitization and 21-46% achieved sustained unresponsiveness. Cow's milk and egg OIT also demonstrated desensitization in 50-75% of children. Wheat OIT studies found 52-69% achieved desensitization. OIT was effective at increasing tolerance but also increased rates of adverse events during treatment.
This document summarizes X-linked agammaglobulinemia (XLA), an inherited primary immunodeficiency caused by mutations in the Bruton's tyrosine kinase (Btk) gene. XLA is characterized by absent B cells and low immunoglobulin levels, leading to recurrent bacterial infections starting in infancy. Management involves immunoglobulin replacement and antibiotic therapy. With treatment, life expectancy has improved dramatically though complications can include lung disease. The document also briefly discusses other forms of agammaglobulinemia caused by defects in genes important for early B cell development.
This document discusses histamine and anti-histamines. It provides information on:
1. The structure and function of histamine and its receptors in immune response regulation. Histamine plays a role in processes like antigen presentation and influencing T and B cell responses.
2. The classification and structures of different types of anti-histamines, including first and second generation anti-histamines from different chemical classes.
3. Some anti-histamines have the potential to cause hypersensitivity in rare cases, even those from different chemical classes with no structural similarity.
The document discusses beta-lactam allergy, including penicillin and cephalosporin allergies. It covers the epidemiology, classifications, structures, mechanisms, and investigations of beta-lactam allergies. Specifically, it notes that penicillin is the most commonly reported antibiotic allergy. It describes the hapten concept of small molecules like beta-lactams binding covalently to proteins to form antigen complexes. Skin testing and in vitro tests are used to investigate immediate IgE-mediated allergies, while patch testing is used for delayed reactions.
This document provides an overview of intravenous immunoglobulin (IVIG) therapy. It discusses the structure and classes of immunoglobulins, mechanisms of action including neutralization, opsonization, and modulation of immune cells. It also covers the manufacturing process, pharmacokinetics, indications for use in primary immunodeficiencies and autoimmune diseases, dosing, administration, and adverse effects. The differences between IVIG products are also reviewed.
More from Chulalongkorn Allergy and Clinical Immunology Research Group (20)
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
2. OUTLINE
Introduction
Normal Immunoglobulin E Production
Immunoglobulin E in Allergic disease
Immunoglobulin E in Infectious disease and Parasitic disease
Immunoglobulin E in Nonatopic Disease
Environmental Exposure and Immunoglobulin E
3. INTRODUCTION
Ig E is present in the smallest quantities
Contributing only 0.02% of circulating Ig
Concentration of IgE are typically report as nanograms
or international unit per volume of serum
• 1 IU is equal 2.4 ng of protien
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
4. INTRODUCTION
IgE found in all mammals ,including monotremes
Off all immunoglobulin Isotype,IgE has the highest affinity for antigens and for its
receptors
The tremendous biologic amplification link to to IgE & Its receptor is shown the fact that
low concentrations of cell surface IgE can cause life threatening reaction with in minute
Immediate or Type I allergic reaction
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
5. INTRODUCTION
Total serum IgE levels
reflect non specific
changes in protein
production or
catabolism
Total serum IgE levels
reflect the balance or
overall regulation of
the immune system
In some diseases,
factors specifically
stimulate IgE
production
Some disease may
result directly from the
production of IgE
antibodies specific for
certain allergen
6. INTRODUCTION
In 1921 the collaboration of Otto Prausnitz& Heinz
Kustner produce discovery
Kustner,who
had been
highly allergic
to fish since
childhood
Prausnitz,who
sufferd from
grass pollen
hay fever
Kustner ‘s
serum was
inject into
Prausnitz’s skin
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
7. INTRODUCTION
In 1921 the collaboration of Otto Prausnitz& Heinz
Kustner produce discovery
the immediate sensitivity
to the fish was transfer to
the site
conclude that a serum
component was
responsible for
transferring the specific
sensitivity
8. INTRODUCTION
Prausnitz-Kustner reaction
Technique of passively transferring allergic sensitivity
Substance that transferred the sensitivity was called the
reagin
Sera containing reagins were call reaginic
1966 Two groups of investigators identified reagin as a unique
immunoglobulin isotype IgE
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
9. NORMAL IMMUNOGLOBUBULIN E
PRODUCTION
IgE ab production is normally highly regulated,resulting
in minimal IgE concentration in body fluids
Most of the IgE producing plasma cells are found in the
lymphoid tissue(GI tract & Respiratory tract)
The highest concentration of IgE producing plasma cells
have been found in tonsils and adenoids
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
10. NORMAL IMMUNOGLOBUBULIN E
PRODUCTION
Production of IgE Ab is regulated by Th2 cells.
Activated Th2 cells trigger IgE production in a combination B cells through a
combination of signal including
1) Cytokine:IL-4,IL-13
2)Cell surface:CD40L
• The process class switch recombination occur somatic gene arrangements
leading to a gene encoding the ε heavy chain
HANS C. Oettgen .et al .Middleton’s allergy ; 8th edition 2013:364-377
11. NORMAL IMMUNOGLOBUBULIN E
PRODUCTION
• The major IgE function mediated by two receptors
1) FcER1 :high affinity IgE receptors
2)CD23:low affinity receptors
• Aggregation of FcεRI-bound on mast cells & Basophils -- Immediate
hypersensitivity reaction
• IgE bound to CD23 is important in
1) IgE-facilitated Ag uptake by APC & transcellular allergen transport in GI & Respiratory
epithelium
2)Regulation of IgE production
HANS C. Oettgen .et al .Middleton’s allergy ; 8th edition 2013:364-377
13. ONTOGENY OF IMMUNOGLOBULINE E
PRODUCTION
GA 7-10 wks
• Germ line transcripts for the ε chain of IgE are detectable
GA 11 wks
• IgE has been observe in human placental tissue
GA 20 wks
• B cells primed to undergo class switching for IgE production can produce IgE
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
14. ONTOGENY OF IMMUNOGLOBULIN E
PRODUCTION
In developed countries less than 1% of cord serum samples contain
detectable IgE to common allergens
Some of the detected allergen –Specific IgE may be of maternal origin
But allergen-Specific IgE rarely has been demonstrated in cord serum
when IgE Ab to the same allergen were not detectable in mother’s serum
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
15. Philip H. Smith .et al .Middleton’s allergy ; 8th edition
2013:1108-1118
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
16. NORMAL SERUM IMMUNOGLOBULINE E
CONCENTRATION
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
17. NORMAL SERUM IMMUNOGLOBULIN E
CONCENTRATION
Age
Immune
status
Race
Medicati
on
Disease
process
Serum IgE Genetic
Level are also
influence by
Season
of the
year
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108118
19. Found Consistently higher IgE serum level in black all age group
Grundbacher FJ.et al,J ALLergy Clin Immunol 1985;75:651-8
20. NORMAL SERUM IMMUNOGLOBULIN E
CONCENTRATION
• Total serum IgE levels may vary two
fold to fourfold annually sensitive
patient in response to pollen seasons
• The maximum IgE levels are usually
reached 4 to 6 weeks after peak of the
pollen seasons
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
21. NORMAL SERUM IMMUNOGLOBULIN E
CONCENTRATION
Questions have arisen about
-Undetectable
-Absent
Most clinical assays for total IgE have a lower limit of
detection of 2-5 IU/mL.
Conc. of less than 2 IU/mL are reported as undetectable
Some have speculated that undetectable conc. IgE might be
related to autoimmune dis. & recurrent infections
23. NORMAL SERUM IMMUNOGLOBULIN E
CONCENTRATION
In a geographically based cohort of 626 pregnant women
Total serum IgE levels were measured using a standard
assay with a lower limit of detection of 2.0 IU/mL.
Sera with IgE levels less than 2.0 IU/mL were assayed again
using a low IgE protocol with a detection limit of 1.2 IU/mL.
Todd A. et al,Ann Allergy Asthma Immunol 2006;97:650-2
24. NORMAL SERUM IMMUNOGLOBULIN E
CONCENTRATION
3.4% were found to have IgE levels less than 2.0 IU/mL
Todd A. et al,Ann Allergy Asthma Immunol 2006;97:650-2
25. Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
26. IMMUNOGLOBULIN E IN OTHER BODY
FLUID
Nasal washing
Bronchial washing
Nasal polyp tissue
Intestinal fluid
Feces
Saliva
Breast milk
Urine
Tears
Middle ear effusion
Aqueous humor
CSF
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
28. • A LARGE STUDY By Wittig & Coworker
• Calculate the diagnostic sensitivity &
specificity of total serum IgE determination
• Using 3 cutoff levels
• For 570 Asthmatic and 244 Rhinitis Pts
Heinz J et al. J Allergy Clin Immunol. 1980 Oct;66(4):305-13
30. IMMUNOGLOBULIN E IN ALLERGIC
DISEASE
• Marsh & colleagues calculated ->the optimal
total serum IgE level for discriminating
between allergic & non allergic adults was
100 IU/ml
• This cutoff misclassified approximately 20%
of each group
Marsh DG et al.Proc Natl Acad Sci U S A. 1974 Sep;71(9):3588-92.
32. • We studied the relation between the serum total IgE level and airway hyperresponsiveness in the presence
or absence of asthma and other atopic diseases in a birth cohort of children.
M.R.Sears.et al ,N Engl J Med 1992;325:1067-71
• Data from
- a questionnaire regarding respiratory symptoms
-measurements of the serum total IgE level
-airway responsiveness to inhaled methacholine
• Data were obtained for 562 11-year-olds in New Zealand.
35. Diagnose of asthma was strongly relate to Serum IgE
M.R.Sears.et al ,N Engl J Med 1992;325:1067-71
36. IMMUNOGLOBULIN E & RISK OF ASTHMA
OMALIZUMAB
(anti-human IgE monoclonal ab)
• Approved for tx of allergic asthma in individuals 12 years old and
older
• The package insert indicate that IgE levels cannot be measure
accurately after tx
• In most studies total IgE levels increase for several months after
the initiation of tx & then decline to very low level
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
37. IMMUNOGLOBULIN E & RISK OF ASTHMA
Allergic Bronchopulmonary Aspergillosis
An elevated serum IgE level > 416 Iu/ml is one dx criterior ABPA
Level of IgE can be used to follow course of disease
Serum IgE level fall when disease successfully tx with glucocorticoid
Serum Ig E level increase when disease exacerbation
There appears to be an association between dis. Activity &level of anti-Aspergillus
antibody
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
38. IMMUNOGLOBULIN E & RISK OF ASTHMA
Allergic Bronchopulmonary Aspergillosis
Several studies have suggested that tx of ABPA with Omalizumab is effective in
controlling the dis while using sig. lower doses of oral glucocorticoid
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
39. IMMUNOGLOBULIN E &RISK OF ASTHMA
Many physician assume they tx allergic Pts with oral
corticosteroids can reduce serum total IgE conc.
But a study of 1o adults with allergic asthma
demonstrate that 20 mg of oral Prednisolone bid
resulted in increased IgE concentration in all 10
individuals
The increase in IgE was polyclonal ,as shown by
measurement of IgE specific to different allergens
Serum IgG levels were unchange
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
40. IMMUNOGLOBULIN E &RISK OF ASTHMA
Tropical Pulmonary Eosinophilia
Gross elevation of serum IgE
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
41. IMMUNOGLOBULIN E & LUNG FUNCTION
Evaluation of the relationship between total serum IgE
levels & Lung function is complicated by
1)Asthma & IgE conc.
2)Cigarette smoking & IgE conc.
Several studies have suggested that higher total serum
IgE levels are associated with a more rapid decline in
lung function with advancing age
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
42. IMMUNOGLOBULIN IN CORD BLOOD
Because IgE is not normally transferred across the placenta to infant
IgE concentration in cord blood is thought to indicate an infant’s
Basal predisposition to IgE production
If this is true ,cord blood IgE concentrations should be useful
indicator of child’s risk of developing allergic disease
Several early studies suggested that cord blood IgE was usefull
marker of allergic risk
But subsequent studies have failed to show strong association
between cord blood IgE conc. And allergic risk during childhood
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
43. Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
44. DETECTION OF ALLERGEN-SPECIFIC
IMMUNOGLOBULIN E
Clinical value of knowing the mass units of allergen
specific igE :Predictive value of food-specific IgE Ab
levels & positive result food challanges
Information on the relationship between inhalant
allergy specific IgE Ab level & symptoms is not as robust
The strongest relationships have been found between
the total amount of allergen-specific IgE measured and
the levels of exhaled nitric oxide
45. FACTORS AFFECTING IMMUNOGLOBULIN E
LEVELS
Specific IgE Conc.
Age
Degree and Duration
of recent allergen
exposure
Degree and Duration
of exposure to cross
react allergen &IT
46. FACTORS AFFECTING IMMUNOGLOBULIN E
LEVELS
• The level of Specific IgE typically peak
appox 4 wks after seasonal pollen
exposure
• Then gradually fall to nadir before next
pollen season
• Seasonal changes are not usually of
sufficient magnitude to shift and assay
result from –ve to +ve
47. FACTORS AFFECTING IMMUNOGLOBULIN E
LEVELS
• Ig E Ab levels rise after insect stings in
some individuals
• Irrespective of whether the sting
provoked allergic S/S
• General trend of declining allergen-specific
IgE with time has been
documented with insect venom & drug
specific IgE
48. FACTORS AFFECTING IMMUNOGLOBULIN E
LEVELS
• IgE levels tend to decline
during IT
• But part of decline
observed in some studies
might have been result of
IgG Ab formation blocking
to the detection of IgE Ab
50. • Cross sectional study of 2295 Dutch
• 20- 70 yrs of age
• Who were questioned about nasal s/s
& SPT & in vitro test IgE Ab for 9 common
allergens
Droste JHJ .et al. J Allergy Clin Immunol,1996 Apr97;(4):922-32
51. • Cross sectional study of 2295 Dutch
• 20- 70 yrs of age
• Who were questioned about nasal s/s
& SPT & in vitro test IgE Ab for 9 common
allergens
Droste JHJ .et al. J Allergy Clin Immunol,1996 Apr97;(4):922-32
52. • Cross sectional study of 2295 Dutch
• 20- 70 yrs of age
• Who were questioned about nasal s/s
& SPT & in vitro test IgE Ab for 9 common
allergens
Associations between nasal s/s after indoor &
outdoor allergens exposures& positive test
results for specific Ig E Ab were highly
significant
But far from absolute
Droste JHJ .et al. J Allergy Clin Immunol,1996 Apr97;(4):922-32
54. INDICATIONS FOR MEASURING SPECIFIC
IMMUNOGLOBULIN E ANTIBODIES
Two major concerns limit the use of in vitro tests for
allergen specific IgE inUSA
In most cases,In vitro tests are not as sensitive as skin tests for
detecting allergen-Specific IgE
On per test basis,Skin test have lower time &reagent costs
55. INDICATIONS FOR MEASURING SPECIFIC
IMMUNOGLOBULIN E ANTIBODIES
Detection of cross-reactive IgE Ab is a potential problem with in vitro tests
Many individuals allergic to pollens have detectable IgE Ab to foods
20-30% of those with food specific IgE Ab do not report S/S related to
foods
Many of the pollen-food cross reaction may result from profilin ,a highly
conserved molecule among plants
Cross-reactive Ab between food & latex allergens also complicate the
interpretation of in vitro tests for latex specific IgE Ab
56. IMMUNOGLOBULIN E IN INFECTIOUS &
PARASITIC DISEASE
Viral infections
Bacterial infections
Yeast & Fungi
Parasitic disease
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
57. VIRAL INFECTIONS
Respiratory syncytial virus
Williver & colleague were the 1 st report
Peak IgE-RSV titers during acute infection were sig. asso. with risk of
recurrent wheezing episodes during 4 yrs follow up study
Later research suggests IgE Ab are formed in some individuals after viral
infection & immunization
Role of this IgE Ab is relation to vaccine effectiveness & adverse reaction
58. VIRAL INFECTIONS
Epstein-Barr virus infection
Initial rise in IgE concentration for 7-10 days
Follow by a decline
Then a return to baseline levels over a course of wks
to months
59. VIRAL INFECTIONS
Measles
Children who developed measles encephalitis had
highest mean levels IgE Ab(540 IU/ml ) in the 1st
week after onset of rash &slower decline
60. VIRAL INFECTIONS
Rhinovirus Infection
Skoner & coworker
Reported that experimentally induce rhinovirus infection in
adults with AR
Acutely produce a highly sig. increase total serum IgE
No sig. change in IgE levels in non AR
61. VIRAL INFECTIONS
HIV
Increased serum IgE conc. have been reported in HIV-1 Pt
AIDS Pt have remarkably high incidence of allergic reaction to
drugs & environmental allergens
The factors associsted with elevated IgE levels in HIV-1 disease
are not completely understood
The relationship between the progressipon of HIV-1 & IgE levels
has varied among studies
Increase levels of IgE in HIV-1 infection appears to be a poor
prognostic sign
62. BACTERIAL INFECTIONS
IgE specific for S.aureus exotoxins is usually found in Pts with
hyperimmunoglobulinemia E with recurrent infection syndrome
Staphylococcal toxin IgE may be related to various allergic
disease
- Nasal polyps
- Chronic rhinosinusitis
Children develop IgE Ab specific for pertussis & tetanus toxoids
after immunization.
63. YEAST &FUNGI
IgE Ab specific for individuals Ag in Candida albicans :Atopic
dermatitis
IgE Ab to Pityrosporum ovale :Atopic dermatitis of
head,face,neck
Ig Ab to Trichophyton :Asthma
64. IMMUNOGLOBULIN E & PARASITIC
DISEASE
Increased IgE Levels typically occur during helminth parasitic infections
There seem to be an association between increasing levels of tissue invasion and
increasing levels of IgE
The increased IgE conc. are the result of parasitic specific & non specific
polyclonal IgE production
One mechanism proposed to explain the increase in total IgE levels is the
secretion by parasite factor that stimulate production o IL-4 or IL-13 or both
leading to increase IgE levels
Total serum IgE levels typically fall after successful tx of the parasite
65. IMMUNOGLOBULIN E & PARASITIC
DISEASE
The hypothesis that IgE is at least partially protective in parasitic dis. Is
widely debated
Some studies strongly support a protective role for igE Ab ,other studies
show no protective effect
-Schistosomiasis
-Ascaris
-Malaria
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
66. IMMUNOGLOBULIN E IN NONATOPIC
DISEASES
Neoplastic disease
Transplantation
Renal & Liver disease
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-1118
67. NEOPLASTIC DISEASE
IgE Myeloma
Hodgkin disease
Bronchial carcinoma
Breast cancer
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
68. NEOPLASTIC DISEASE
IgE Myelomas
-rare disease
-only 40 case reported
-initial description by Johansson &Bennich in 1967
-the low frequency of igE-myeloma presumably reflects the small No of IgE
producing cells normally presents in the body
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
69. NEOPLASTIC DISEASE
IgE Myelomas
-some IgE myeloma might have been missed because
1) the quantity of IgE produced by the myeloma might have been less than that
detectable by routine screening
2)they might have been misclassified as light chain disease
-IgE conc. At the time of Dx 0.6-63 gm/L
-survival time shorter than other myelomas
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
70. NEOPLASTIC DISEASE
Hodgkin disease
- Associate with increase serum IgE levels
-High IgE conc. Associate with a nodular sclerotic pattern
-IgE levels usually fall with successful tx
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
71. NEOPLASTIC DISEASE
Bronchial carcinoma
-Larger quantities of allergen specific IgE were
associated with poorer prognosis
Breast cancer
-IgE level above the geometric mean for age were
poor prognostic sign (ER +ve)
72. NEOPLASTIC DISEASE
In some animal tumor models,antitumor Ag IgE Ab have
been protective against tumor growth
The anticancer effect of tumor Ag-specific IgE & IgE of
other Ag specificities are being evaluated
In some model systems,the unique properties of
IgE,especially related to ability to attract&activate
eosinophils,appear to have important antitumor effect
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
73. TRANSPLANTATION
Increases in serum IgE levels from 7-fold to 2000-fold have been
reported in pt after BM transplantation
Initially,the increased IgE levels were thought to result from GVHD
But subsequence studies showed that igE levels also increase in pt
who did not have GVHD
Increased IgE conc. do not seem to result from myeloablative or
immunpsuppressive tx use in pt with neoplasia
• Because increased IgE levels have also been observed in
immunodeficient children whom BM with transplant
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
74. RENAL AND LIVER DISEASE
Nephrotic syndrome
Total serum IgE levels are elevated in pt with NS
-Minimal change dis.
- IgM nephropathy
- Focal glomerulosclerosis
- Membranous gromerulonephritis
High IgE level are associate with decrease response of steroid tx
Liver disease
Increased levels of igE
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
75. ENVIRONMENTAL EXPOSURE AND
IMMUNOGLOBULIN E
Cigarette smoking
-Most studies have found increase serum IgE conc.
Alcoholic
-Total IgE levels are increased in atopic & nonatopic
• Diesel exhaust
-Alter nasal local IgE production
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18
76. SUMMARY
Measurement of total IgE levels are not useful in the dx of
allergic disease <---------> Because wide range of normal conc.
Measurement of allergen specific Ig E are useful in the Dx of
allergic disease <---------> When they are interpreted in the
context of an individual’ medical hx
Philip H. Smith .et al .Middleton’s allergy ; 8th edition 2013:1108-18